Equashield IPO
Equashield develops closed system transfer devices (CSTDs) and safety solutions for handling hazardous drugs in healthcare settings. The company's products help protect healthcare workers from exposure to cytotoxic and hazardous medications during preparation and administration. Investors are interested in Equashield's specialized healthcare safety technology and its applications in oncology and pharmacy settings.
Key Facts
| Industry | Medical Devices |
| Founded | 2008 |
| Headquarters | Yokneam, Israel |
| Employees | ~300 |
| Website | equashield.com |
About Equashield
Equashield develops closed system transfer devices (CSTDs) and safety solutions for handling hazardous drugs in healthcare settings, particularly for oncology and other toxic medications. The company's products are designed to protect healthcare workers, patients, and the environment from exposure to hazardous drugs during preparation, administration, and disposal processes. Equashield's systems feature innovative air filtration and sealing technology that prevents contamination while maintaining drug sterility and potency. The company has gained significant market traction as healthcare systems worldwide have increased focus on worker safety and regulatory compliance around hazardous drug handling, with their products being adopted by major hospital systems and cancer treatment centers globally.
IPO Status
Equashield has not announced any plans for an initial public offering and continues to operate as a private medical device company. The company focuses on the specialized market of healthcare worker safety equipment, particularly for handling hazardous drugs, but has not disclosed IPO timeline or valuation details. As a niche healthcare technology company serving hospitals and pharmacies, Equashield operates in a regulated industry that typically requires substantial revenue and market penetration before considering public offerings. The company has provided no confirmed details about IPO preparations or plans to go public.
Competitors
Frequently Asked Questions
Does Equashield have a stock?
No, Equashield has not had an IPO and remains a privately-held medical device company. The company has not announced any plans to go public.
When is the Equashield IPO date?
There is no confirmed IPO date for Equashield, as the company has not announced plans to go public. No timeline has been disclosed.
How can I buy Equashield stock?
Equashield stock cannot be purchased by public investors as the company is private and not listed on stock exchanges. Shares are not available for public trading.
Stay Updated on the Equashield IPO
Get real-time alerts when Equashield files for an IPO, prices shares, or begins trading.
Get IPO Alerts